Novavax kicks off late-stage trial for new seasonal flu vaccine

Novavax Inc. has officially started a late-stage clinical trial for its seasonal flu vaccine, a critical phase for the Gaithersburg biotech vying for a much-needed win this time around.The company is launching the phase 3 study for NanoFlu, its seasonal influenza candidate, after several devastating disappointments this year, starting with a failed late-stage trial for ResVax, its RSV vaccine for newborns given through maternal immunization. That news had battered the company with a tanking stoc